Drugs for Parasitic Protozoa Infectious Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 30)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Amodiaquine |
Approved, Investigational |
Phase 3 |
|
86-42-0 |
2165 |
Synonyms:
||SN 10,751
2aou
4-((7-Chloro-4-quinolinyl)amino)-2-((diethylamino)methyl)phenol
4-((7-Chloro-4-quinolyl)amino)-alpha-(diethylamino)-o-cresol
4-(7-Chloro-quinolin-4-ylamino)-2-diethylaminomethyl-phenol
4-[(7-Chloro-4-quinolinyl)amino]-2-[(diethylamino)methyl]phenol
4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol
4-[(7-CHLOROQUINOLIN-4-YL)AMINO]-2-[(DIETHYLAMINO)METHYL]PHENOL
5-22-10-00283 (Beilstein Handbook Reference)
7-Chloro-4-(3-diethylaminomethyl-4-hydroxyanilino)
7-Chloro-4-(3-diethylaminomethyl-4-hydroxyanilino)quinoline
7-Chloro-4-(3-diethylaminomethyl-4-hydroxyphenylamino)quinoline
86-42-0
AC-13295
AC1L1D2F
AKOS000538864
Amodiachin
Amodiachinum
Amodiaquin
Amodiaquina
Amodiaquina [INN-Spanish]
amodiaquine
Amodiaquine
Amodiaquine (USAN/INN)
Amodiaquine [USAN:INN:BAN]
amodiaquine hydrochloride
Amodiaquine hydrochloride
Amodiaquine usp24
Amodiaquine USP24
AMODIAQUINE, FLAVOQUINE
Amodiaquine, ring-closed
Amodiaquinum
Amodiaquinum [INN-Latin]
BAS 00327385
Basoquin
Bio-0471
BPBio1_000306
BRN 0300962
BSPBio_000278
C07626
C20H22ClN3O
CAM-AQ 1
Cam-AQ1
|
CAM-AQ1
CAM-AQI
Camochin
Camoquin
Camoquin HCL
Camoquinal
Camoquine
CCRIS 8486
CHEBI:2674
CHEMBL682
CID2165
CPD-10889
CQA
D02922
DB00613
EINECS 201-669-3
Flavoquin
Flavoquine
HSDB 7457
Hydrochloride, amodiaquine
LS-55353
Miaquin
MLS001304065
MolPort-001-924-563
NSC 13453
NSC13453
o-Cresol, 4-[(7-chloro-4-quinolyl)amino]-.alpha.-(diethylamino)- (6CI,7CI,8CI)
Oprea1_019229
Prestwick0_000309
Prestwick1_000309
Prestwick2_000309
Prestwick3_000309
Quinoline, 7-chloro-4-[[3-[(diethylamino)methyl]-4-hydroxyphenyl]amino]-|
Roussel brand OF amodiaquine hydrochloride
S. N. 10751
SMR000718769
SN 10,751
SN 10751
SPBio_002497
Sunoquine
UNII-220236ED28
WR-002977
|
|
2 |
|
Primaquine |
Approved |
Phase 3 |
|
90-34-6 |
4908 |
Synonyms:
(-)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
()-Primaquine
(-)-Primaquine
(+)-N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
(+)-Primaquine
(+/-)-Primaquine
1,4-Pentanediamine, N4-(6-methoxy-8-quinolinyl)- (9CI)
4-22-00-05817 (Beilstein Handbook Reference)
4-N-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
63-45-6
63-45-6 (1:2 PO4)
6-Methoxy-8-(4-amino-1-methylbutylamino)quinoline
6-Methoxy-8-[(4-amino-1-methylbutyl)amino]quinoline
6-Methoxy-8-[4-amino-1-methylbutylamino]quinoline
8-((4-amino-1-Methylbutyl)amino)-6-methoxyquinoline
8-((4-Amino-1-methylbutyl)amino)-6-methoxyquinoline
8-(4-Amino-1-m
8-(4-amino-1-methylbutylamino)-6-Methoxyquinoline
8-(4-Amino-1-methylbutylamino)-6-methoxyquinoline
8-[(4-Amino-1-methylbutyl)amino]-6-methoxyquinoline
90-34-6
AB00053529
AC1L1J80
AC1Q4F0C
AC1Q4F4Q
Boucher and muir brand OF primaquine phosphate
BPBio1_000674
BRN 0019337
BSPBio_000612
BSPBio_002223
C07627
CCRIS 4109
CHEBI:8405
CHEMBL506
CID4908
D08420
DB01087
Diphosphate, primaquine
DivK1c_000806
dl-Primaquine
EINECS 201-987-2
ethylbutylamino)-6-methoxyquinoline
HMS2090J17
HSDB 6516
I08-0048
IDI1_000806
Kanaprim
Kanaprim (TN)
KBio1_000806
KBio2_001310
KBio2_003878
KBio2_006446
KBio3_001723
KBioGR_000967
KBioSS_001310
LS-141312
MolPort-001-794-628
|
N(4)-(6-methoxyquinolin-8-yl)pentane-1,4-diamine
N-(5-aminopentan-2-yl)-6-methoxyquinolin-8-amine
N~4~-[6-(methyloxy)quinolin-8-yl]pentane-1,4-diamine
N4-(6-Methoxy-8-quinolinyl)-1,4-pentanediamine
NCGC00178754-01
NCGC00178754-02
NCI60_001035
NCI60_005887
neo-Quipenyl
Neo-Quipenyl
NINDS_000806
NSC 27296
NSC27296
Oprea1_546209
Phosphate, primaquine
PQ
Prestwick0_000476
Prestwick1_000476
Prestwick2_000476
Prestwick3_000476
Primachin
Primachina
Primachina [DCIT]
Primachinum
Primacin
Primaquin
Primaquina
Primaquina [INN-Spanish]
Primaquine
PRIMAQUINE
Primaquine (INN)
Primaquine [INN:BAN]
Primaquine Bis-Phosphoric Acid
Primaquine diphosphate
Primaquine phosphate
Primaquinum
Primaquinum [INN-Latin]
Quinoline, 8-(4-amino-1-methylbutylamino)-6-methoxy
Quinoline, 8-[(4-amino-1-methylbutyl)amino]-6-methoxy- (6CI,8CI)
S. N. 13272
SMP1_000263
SN 13,272
SN 13272
SPBio_000674
SPBio_002551
Spectrum_000830
Spectrum2_000887
Spectrum3_000552
Spectrum4_000484
Spectrum5_001363
STOCK5S-90838
TG1-296
TG1-297
UNII-MVR3634GX1
WLN: T66 BNJ HO1 JMY1&3Z
WR 2975
|
|
3 |
|
Mefloquine |
Approved, Investigational |
Phase 3 |
|
53230-10-7 |
4046 |
Synonyms:
(-)-(11S,2'R)-erythro-Mefloquine
(-)-Mefloquine
(-)-Threo-Mefloquine
(+)-(11R,2'S)-erythro-Mefloquine
(+)-Mefloquine
(+)-Threo-Mefloquine
(DL-erythro-alpha-2-Piperidyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(R)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl][(2R)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2R)-piperidin-2-yl]methanol
(S)-[2,8-bis(trifluoromethyl)quinolin-4-yl]-[(2S)-piperidin-2-yl]methanol
[(R*,S*)-2,8-bis(trifluoromethyl)quinolin-4-yl]-(2-piperidyl)methanol
[2,8-bis(trifluoromethyl)quinolin-4-yl]-piperidin-2-ylmethanol
49752-90-1
51688-68-7
51742-87-1
51744-84-4
51744-85-5
53230-10-7
68682-27-9
a-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
AB00052310
AC1L1HAJ
AC1L249S
AC1L9UO6
AC1MHD7J
AC1MHD7O
AC1Q4K1I
alpha-2-Piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
alpha-2-Piperidyl-2,8-bis(trifluoromethyl)quinoline-4-methanol
AR-1G4597
BIDD:GT0596
BIDD:PXR0166
BPBio1_000190
BRD-A89585551-003-03-4
BSPBio_000172
C07633
C17H16F6N2O
CAS-51773-92-3
CHEBI:151162
CHEBI:403542
CHEMBL411329
CHEMBL411685
CHEMBL411686
CHEMBL416956
CID3000506
CID3000516
CID4046
CID40692
CID456309
D04895
DB00358
DivK1c_000790
EINECS 256-468-3
Erthro-.alpha.-[2-piperidyl]-2,8-bis[trifluoromethyl]-4-quinolinemethanol
HMS1922C09
HMS502H12
Hoffmann la roche brand OF mefloquine hydrochloride
Hoffmann-la roche brand OF mefloquine hydrochloride
HSDB 6853
IDI1_000790
KBio1_000790
KBio2_001792
KBio2_004360
KBio2_006928
KBio3_002046
|
KBioGR_001392
KBioSS_001792
Lariam
Lariam (Hydrochloride)
LS-142023
LS-187797
Mefloquin
Mefloquina
Mefloquina [INN-Spanish]
mefloquine
Mefloquine
Méfloquine
Mefloquine (USAN/INN)
Mefloquine [USAN:INN:BAN]
Mefloquine aziridine
Mefloquine HCL
Mefloquine hydrochloride
Mefloquinone
Mefloquinum
Mefloquinum [INN-Latin]
Mephloquine
MolPort-003-981-155
MQ
NCGC00016864-01
NCGC00094994-01
NCGC00094994-02
NCGC00094994-03
NCGC00094994-04
NCGC00161831-01
NCGC00161831-02
nchembio.215-comp3
nchembio.87-comp20
NINDS_000790
NSC157387
Prestwick0_000126
Prestwick1_000126
Prestwick2_000126
Prestwick3_000126
Racemic mefloquine
RO 13-7224
RO 13-7225
Ro 215998
Ro 21-5998
Ro 21-5998 (Hydrochloride)
Ro-21-5998-001
Roche brand OF mefloquine hydrochloride
RTI1169-1-1
RTI1172-1-1
RTI1173-1-1
RTI1174-1-1
RTI1188-1-1
RTI1189-1-1
SPB-80406
SPBio_001591
SPBio_002111
Spectrum_001312
SPECTRUM1503070
Spectrum2_001516
Spectrum3_000953
Spectrum4_001066
Spectrum5_001122
UNII-TML814419R
WR 142490
WR-142,490
WR-142490
WR-177,602
α-2-piperidinyl-2,8-bis(trifluoromethyl)-4-quinolinemethanol
|
|
4 |
|
Albendazole |
Approved, Vet_approved |
Phase 3 |
|
54965-21-8 |
2082 |
Synonyms:
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle
((Propylthio)-5 1H-benzimidazolyl-2) carbamate de methyle [French]
(5-(propylthio)-1H-Benzimidazol-2-yl)carbamate methyl ester
(5-(propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-(propylthio)-1H-Benzimidazol-2-yl)carbamic acid methyl ester
(5-(Propylthio)-1H-benzimidazol-2-yl)carbamic acid methyl ester
(5-Propylsulfanyl-1H-benzoimidazol-2-yl)-carbamic acid methyl ester
[5-(Propylthio)benzimidazol-2-yl]carbamic Acid Methyl Ester
[5-(Propythio)-1H-benzimidazol-2-yl]carbamic acid methyl ester
5-(propylthio)-2-carbomethoxyaminobenzimidazole
5-(propylthio)-2-Carbomethoxyaminobenzimidazole
5-(Propylthio)-2-carbomethoxyaminobenzimidazole
54965-21-8
A4673_FLUKA
A4673_SIGMA
AB00052377
AC-015
AC1L1CVL
AC1Q2YKD
AKOS000540882
Albendazol
Albendazol [INN-Spanish]
albendazole
Albendazole
Albendazole (JAN/USP/INN)
Albendazole [USAN:INN:BAN:JAN]
Albendazole armstrong brand
Albendazole Armstrong Brand
Albendazole diba brand
Albendazole Diba Brand
Albendazole fustery brand
Albendazole Fustery Brand
Albendazole hormona brand
Albendazole Hormona Brand
Albendazole liferpal brand
Albendazole Liferpal Brand
Albendazole monohydrochloride
Albendazole Monohydrochloride
Albendazole Noe-Socopharm Brand
Albendazole noé-socopharm brand
Albendazole pfizer brand
Albendazole Pfizer Brand
Albendazole sanicoopa brand
Albendazole Sanicoopa Brand
Albendazole valdecasas brand
Albendazole Valdecasas Brand
Albendazolum
Albendazolum [INN-Latin]
Albendoral
Albenza
Albenza (TN)
Albenza, Eskazole, Zentel, Andazol, Albendazole
Armstrong brand OF albendazole
Armstrong Brand of Albendazole
BAS 00439961
BB_SC-1386
Bendapar
BIDD:GT0615
Bilutac
BIM-0051849.0001
BPBio1_000038
BRD-K79131256-001-04-7
BSPBio_000034
BSPBio_002548
C01779
CARBAMIC ACID, (5-(PROPYLTHIO)-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER
Carbamic acid, [5-(propylthio)-1H-benzimidazol-2-yl]-, methyl ester
CAS-54965-21-8
CHEBI:16664
CHEBI:506787
CHEMBL1483
ChemDiv1_000190
ChemDivAM_000003
CID2082
CPD000036735
D00134
D015766
DB00518
Diba brand OF albendazole
Diba Brand of Albendazole
Digezanol
Disthelm
Disthelm, mediamix V
Disthelm, Mediamix V
DivK1c_000704
EINECS 259-414-7
Endoplus
Eskazole
Fustery brand OF albendazole
Fustery Brand of Albendazole
Gascop
HMS1568B16
HMS1922K04
HMS2090G19
HMS2093K13
HMS502D06
HMS587I14
Hormona brand OF albendazole
|
Hormona Brand of Albendazole
HSDB 7444
I01-0380
IDI1_000704
InChI=1/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)
KBio1_000704
KBio2_002012
KBio2_004580
KBio2_007148
KBioGR_000801
KBioSS_002012
Liferpal brand OF albendazole
Liferpal Brand of Albendazole
LS-50618
Lurdex
Mediamix V disthelm
Mediamix V Disthelm
methyl [(2Z)-5-(propylsulfanyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]carbamate
methyl [5-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
methyl [5-(propylthio)-1H-benzimidazol-2-yl]carbamate
Methyl [5-(Propylthio)benzimidazol-2-yl]carbamate
methyl [6-(propylsulfanyl)-1H-benzimidazol-2-yl]carbamate
Methyl 5-(propylthio)-2-benzimidazolecarbamate
Methyl 5-(propyl-thio)-2-benzimidazolecarbamate
methyl N-(6-propylsulfanyl-1H-benzimidazol-2-yl)carbamate
methyl N-[6-(propylsulfanyl)-1H-1,3-benzodiazol-2-yl]carbamate
Methyl-5-[propylthio]-2-benzimidazole carbamate
Metiazol
MLS000069722
MolPort-000-726-929
MolPort-000-760-571
MolPort-001-932-918
Monohydrochloride, albendazole
Monohydrochloride, Albendazole
NCGC00016876-01
NCGC00016876-02
NCGC00022896-03
NCGC00022896-04
NCGC00022896-05
NCGC00022896-06
NCGC00022896-07
NINDS_000704
Noe Socopharm Brand of Albendazole
Noé socopharm brand OF albendazole
Noe-Socopharm Brand of Albendazole
Noé-socopharm brand OF albendazole
NSC 220008
NSC220008
O-methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamate
O-Methyl N-(5-(propylthio)-2-benzimidazolyl)carbamic acid
Oprea1_429292
Oprea1_585016
Oprea1_640007
Pfizer brand OF albendazole
Pfizer Brand of Albendazole
Prestwick_675
Prestwick0_000247
Prestwick1_000247
Prestwick2_000247
Prestwick3_000247
Proftril
S1640_Selleck
SAM002589939
Sanicoopa brand OF albendazole
Sanicoopa Brand of Albendazole
SK And F 62979
SK And F62979
SK And F-62979
SK&F 62979
SK&F62979
SK&F-62979
SKF 62979
SKF62979
SKF-62979
Smith Kline & French Brand of Albendazole
SmithKline beecham brand OF albendazole
SmithKline Beecham Brand of Albendazole
SMR000036735
SPBio_002253
Spectrum_001532
SPECTRUM1503903
Spectrum4_000201
Spectrum5_001567
STK387550
STL046130
STOCK2S-67946
TL8003543
UNII-F4216019LN
V Disthelm, mediamix
V Disthelm, Mediamix
Valbazen
Valdecasas brand OF albendazole
Valdecasas Brand of Albendazole
VU0239747-6
Zental
Zentel
ZINC17146904
|
|
5 |
|
Quinine |
Approved |
Phase 3 |
|
130-95-0 |
8549 3034034 |
Synonyms:
(−)-quinine
(-)-Quinine
(+)-Quinidine
(1R)-(6-Methoxyquinolin-4-yl)((1S,4S,5R)-5-vinylquinuclidin-2-yl)methanol
(3|A,8|A,9r)-6'-methoxycinchonan-9-ol
(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(8.alpha.,9R)-6'-Methoxycinchonan-9-ol
(8-alpha,9R)-6'-Methoxycinchonan-9-ol
(8S,9R)-6'-Methoxycinchonan-9-ol
(8S,9R)-quinine
(8S,9R)-Quinine
(9R)-6'-methoxy-8alpha-cinchonan-9-ol
(R)-(-)-quinine
(R)-(−)-quinine
(R)-(-)-Quinine
(R)-(-)-Quinine, 6-methoxycinchonidine
(R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-Methoxyquinolin-4-yl)((2S,4S,8R)-8-vinylquinuclidin-2-yl)methanol
(R)-(6-Methoxy-quinolin-4-yl)-((2S,5S)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol
(R)-[(2S,4R,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
(S)-(5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl)-(6-methoxyquinolin-4-yl)methanol
(S)-[(2R,4R,5S)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
.alpha.-(6-Methoxy-4-quinoyl)-5-vinyl-2-quinclidinemethanol
12239-42-8
128544-03-6
130-89-2
130-95-0
1407-83-6
145904_ALDRICH
21480-31-9
22620_FLUKA
22620_SIGMA
549-56-4
55980-20-6
56-54-2
6119-70-6
6183-68-2
6912-57-8
6'-Methoxycinchonan-9-ol
6'-Methoxycinchonidine
6'-Methoxycinchonine
6-Methoxycinchonine
72646-90-3
767303-40-2
804-63-7
840482-04-4
857212-53-4
864908-93-0
875538-34-4
888714-03-2
890027-24-4
894767-09-0
898813-59-7
898814-28-3
899813-83-3
900786-66-5
900789-95-9
906550-97-8
909263-47-4
909767-48-2
909882-78-6
910878-25-0
910880-97-6
911445-75-5
918778-04-8
AC1L1ANE
AC1L1R7Y
AC1L9AHT
AC1LCUGN
AC1MHWS7
AC1MI1Q5
AC1Q4EZ5
AC1Q58AF
Aflukin
Alphapharm brand OF quinine sulfate
AR-1A4833
AR-1H2065
Aventis brand OF quinine bisulfate
BB_NC-0697
beta-Quinine
Biquinate
Biquinate (*Bisulfate heptathydrate*)
Bisulfate, quinine
C06526
C20H24N2O2
CCRIS 5755
CHEBI:111177
CHEBI:15854
CHEMBL170
CHEMBL97
Chinin
Chinin [German]
Chinine
chininum
Chininum
CID1065
CID3034034
CID3036746
CID441073
CID637552
CID8549
Cinchonan-9-ol, 6'-methoxy-, (8.alpha.,9R)-, sulfate
Cin-Quin
Coco-Quinine
Conchinin
|
Conquinine
D08460
DB00468
Dentojel (*Bisulfate heptathydrate*)
EINECS 205-003-2
EINECS 215-805-4
Fawns and mcallan brand OF quinine bisulfate
Fawns and mcallan brand OF quinine sulfate
Foy brand OF quinine sulfate
HMS1607A11
HMS1791J11
HMS2089E05
Hoechst brand OF quinine sulfate
HSDB 2501
Hydrochloride, quinine
I14-3348
I14-3397
IBS-L0034250
InChI=1/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H
Innotech brand OF quinine hydrochloride
Kinder Quinina
Kinder Quinina (TN)
KST-1A1085
L001278
Lafran brand OF quinine hydrochloride
Legatrim
Lopac0_001029
LS-141252
LS-194958
LS-4562
LT00645788
MLS001304041
MolPort-000-146-082
MolPort-001-766-747
MolPort-002-507-196
MolPort-003-901-021
Myoquin
NCGC00015871-03
NCGC00142453-01
NCGC00159499-02
NCGC00159499-03
NCGC00162322-01
NCGC00162322-02
NCGC00163142-03
NCGC00166281-01
nchem.1039-compI
nchem.180-comp1a
nchembio.215-comp5
nchembio.368-comp9
nchembio.87-comp19
NCI60_004320
NSC 192949
NSC 5362
NSC131458
NSC192949
NSC5362
NSC667852
Odan brand OF quinine sulfate
Plough brand OF quinine sulfate
Prosana brand OF quinine bisulfate
Q0028
Quinamm
Quinamm (*2:1 Sulfate salt*), dihydrate
Quinbisan
Quinbisul
Quindan
Quine (*2:1 Sulfate salt*, dihydrate)
Quinidex
quinidine
Quinimax
quinina
Quinina
Quinine
Quinine (BAN)
Quinine [BAN]
Quinine anhydrous
Quinine bisulfate
Quinine Dab
Quinine hydrochloride
Quinine lafran
QUININE MONO HCL
quinine sulfate
Quinine sulfate
Quinine sulphate
Quinine, anhydrous
Quinine, Anhydrous
Quinine, polymers
Quinine, tannate
Quinineanhydrous
Quinine-odan
Quinoctal
Quinoline alkaloid
Quinoline Alkaloid
Quinora
Quinsan (*2:1 Sulfate salt*), dihydrate
Quinson
Quinsul
Quniacridine
SB01652
SMR000718748
ST056282
Strema
Sulfate, quinine
Sulphate, quinine
Surquina
UNII-A7V27PHC7A
WLN: T66 BNJ HO1 EYQ-DT66 A B CNTJ A1U1
|
|
6 |
|
Piperaquine |
Experimental, Investigational |
Phase 3 |
|
4085-31-8 |
5079497 |
Synonyms:
1,3-bis(1-(7-chloro-4'-quinolyl)-4'-piperazinyl)propane
1,3-bis(4-(7'-chloro-4'-quinoline)-1-piperazine)
1,3-bis[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propane
4,4'-(propane-1,3-diyldipiperazine-4,1-diyl)bis(7-chloroquinoline)
4085-31-8
5-23-03-00072 (Beilstein Handbook Reference)
7-chloro-4-[4-[3-[4-(7-chloroquinolin-4-yl)piperazin-1-yl]propyl]piperazin-1-yl]quinoline
83764-65-2
AC1L3UA1
AC1Q3T7B
AR-1F7471
BRN 0905079
|
C29H32Cl2N6
CHEMBL303933
CID122262
FT-0082661
I06-1673
LS-142194
piperaquine
Piperaquinoline
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro- (9CI)
Quinoline, 4,4'-(1,3-propanediyldi-4,1-piperazinediyl)bis(7-chloro-)
ST51053186
|
|
7 |
|
Dihydroartemisinin |
Experimental, Investigational |
Phase 3 |
|
71939-50-9 |
6918483 |
Synonyms:
(3R,5aS,6R,8aS,9R,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepin-10-ol
[3R-(3.alpha.,5a.beta.,6.beta.,8a.beta.,9.alpha.,10.alpha.,12.beta.,12aR*)]-Decahydro-10-hydroxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4.3-j]-1,2-benzodioxepin
1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-ol(Dihydroartemisinin)
71939-50-9
81496-81-3
AC1L32PY
AC1L9UV6
AC-2067
Ambotz71939-50-9
Artenimol
Artenimol (INN)
beta-Dihydroartemisinin
CHEBI:207229
CHEMBL25164
CID107770
|
CID456410
CID6918483
Cotecxin
D07362
D3793
Dihydroartemisinin
Dihydroartemisinine
Dihydroqinghaosu
Dihydroquinghaosu
Dihydroquinghoasu
GNF-PF-5634
JAV-110
LS-64240
VM3352
|
|
8 |
|
Artemisinins |
|
Phase 3 |
|
|
|
9 |
|
Artemisinine |
|
Phase 3 |
|
|
|
10 |
|
Anthelmintics |
|
Phase 3 |
|
|
|
11 |
|
Tubulin Modulators |
|
Phase 3 |
|
|
|
12 |
|
Antimitotic Agents |
|
Phase 3 |
|
|
|
13 |
|
Red Cinchona |
|
Phase 3 |
|
|
|
14 |
|
Nitazoxanide |
Approved, Investigational, Vet_approved |
Phase 1, Phase 2 |
|
55981-09-4 |
41684 |
Synonyms:
(2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat
[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate
2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide
2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate
2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide
55981-09-4
AC-1302
AC1L26A1
AC1Q5NVY
Alinia
Alinia (TN)
AZT + Nitazoxanide
azt+ nitazoxanide
BRN 1225475
C12H9N3O5S
CHEMBL1401
CID41684
Colufase
Columbia brand 1 OF nitazoxanide
Columbia brand 2 OF nitazoxanide
Columbia brand 3 OF nitazoxanide
CPD000466367
Cryptaz
D02486
Daxon
Daxon, Dexidex, Kidonax, Pacovanton, Paramix, Nitax, Zox, Nitazoxanide
DB00507
EINECS 259-931-8
FT-0082459
Heliton
HMS2051L04
I14-6011
LS-144176
MLS000759492
MLS001424074
MolPort-002-042-244
|
N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)
N-(5-Nitrothiazol-2-yl)salicylamide acetate ester
NCGC00090774-01
NCI60_034935
NCIMech_000843
Nitaxozanid
Nitaxozanide
Nitazoxanid
Nitazoxanida
Nitazoxanida [INN-Spanish]
Nitazoxanide
NITAZOXANIDE
Nitazoxanide (USAN/INN)
Nitazoxanide [USAN:INN]
Nitazoxanidum
Nitazoxanidum [INN-Latin]
NSC 697855
NSC697855
NTZ
o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate
Oprea1_263587
Phavic-1
Romark brand 1 OF nitazoxanide
Romark brand 2 OF nitazoxanide
S1627_Selleck
Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester)
Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester)
SAM001246708
SBB068315
SMR000466367
STK395664
Taenitaz
Tizoxanide glucuronide
UNII-SOA12P041N
ZINC03956788
|
|
15 |
|
Anti-Infective Agents |
|
Phase 1, Phase 2 |
|
|
|
16 |
|
Antiparasitic Agents |
|
Phase 1, Phase 2 |
|
|
|
17 |
|
Analgesics, Non-Narcotic |
|
Phase 1, Phase 2 |
|
|
|
18 |
|
Analgesics |
|
Phase 1, Phase 2 |
|
|
|
19 |
|
Mesalamine |
|
Phase 1, Phase 2 |
|
89-57-6 |
|
20 |
|
Anti-Inflammatory Agents |
|
Phase 1, Phase 2 |
|
|
|
21 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 1, Phase 2 |
|
|
|
22 |
|
Antirheumatic Agents |
|
Phase 1, Phase 2 |
|
|
|
23 |
|
Artemether |
Approved |
Phase 1 |
|
71963-77-4 |
68911 9796294 119380 |
Synonyms:
( )-alpha-Artemether
(1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
(1R,4S,5R,8S,9R,10S,12R,13R)-10-Methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane
(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12beta,12aR*)-isomer of artemether
(3r,5as,6r,8as,9r,10r,12r,12ar)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxypyrano[4,3-j][1,2]benzodioxepine
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin
(5aS,6R,8aS,9R,10S,12R,12aR)-10-methoxy-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromene
.beta.-Artemether
.beta.-Dihydroartemisinin methyl ether
.beta.-Methylether of 11-epi-dihydroartemisinin
10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
10-Methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane
159573-83-8
3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin, decahydro-10-methoxy-3,6,9-tri
71939-51-0
71963-77-4
74784-06-8
80286-56-2
93787-85-0
AC1L2APD
AC1L2XO8
AC1L9SH2
AC1L9UV0
AC1MI2ZX
AC1Q6Z74
AC1Q6Z7V
alpha-Artemether
alpha-Dihydroartemisinin methyl ether
AR-1A4424
Arteannuin ether
Artemetero
Artemetero [INN-Spanish]
Artemether
Artemether (INN)
Artemether [INN]
artemether, (3R-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12aR*))-isomer
artemether[inn]
Artemetheri
Artemetherum
Artemetherum [INN-Latin]
Artemisininelactol methyl ether
Artemos
Artenam
Artesaph
Artesian
Artimist
Artmether
b-Artemether
b-Dihydroartemisinin methyl ether
beta-Artemether
|
beta-Dihydroartemisinin methyl ether
BRN 5948416
C16H26O5
CHEBI:195280
CHEMBL411864
CHEMBL512315
CID10266705
CID104888
CID3062122
CID456408
CID500199
CID6483308
CID6712286
CID68911
CID9796294
CID9796295
CPD000469218
D02483
DB06697
dihydroartemisinin methyl ether
Dihydroartemisinin methyl ether
Dihydroqinghaosu methyl ether
Dihydroquinghaosu methyl ether
Falcidol
Gvither
HMS2052L09
HSDB 7456
I06-0205
KST-1A8041
LS-176935
LS-64237
Malartem
methyl-dihydroartemisinine
Methyl-dihydroartemisinine
MLS001424249
NCI60_022891
NSC 665970
NSC665970
O-Methyldihydroartemisinine
Paluther
rither
S2264_Selleck
SAM001246799
SM 224
SM 229
SM-224
SMR000469218
UNII-C7D6T3H22J
β-artemether
β-dihydroartemisinin methyl ether
|
|
24 |
|
Lumefantrine |
Approved |
Phase 1 |
|
82186-77-4 |
6437380 |
Synonyms:
(+-)-2,7-dichloro-9-((Z)-P-Chlorobenzylidene)-a-((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-dichloro-9-((Z)-P-Chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-alpha-((dibutylamino)methyl)fluorene-4-methanol
(+-)-2,7-dichloro-9-((Z)-P-Chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
(±)-2,7-Dichloro-9-((Z)-p-chlorobenzylidene)-α-((dibutylamino)methyl)fluorene-4-methanol
120583-69-9
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-(4-chlorobenzylidene)-9H-fluoren-4-yl]ethanol
2-(dibutylamino)-1-[(9Z)-2,7-dichloro-9-[(4-chlorophenyl)methylidene]fluoren-4-yl]ethanol
2-dibutylamino-1-[2,7-dichloro-9-(4-chloro-Benzylidene)-9H-fluoren-4-yl]-ethanol
2-Dibutylamino-1-[2,7-dichloro-9-(4-chloro-benzylidene)-9H-fluoren-4-yl]-ethanol
2-dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
2-Dibutylamino-1-{2,7-dichloro-9-[1-(4-chloro-phenyl)-meth-(Z)-ylidene]-9H-fluoren-4-yl}-ethanol
82186-77-4
AC1O5NKD
AC-4542
benflumetol
Benflumetol
Benflumetol, (-)-isomer
Benflumetol, (+)-isomer
|
Benflumetol, (+-)-isomer
Bio-0132
C30H32Cl3NO
CHEBI:156095
CHEMBL38827
CID6437380
Coartem
D03821
DB06708
dl-Benflumelol
DL-Benflumelol
HSDB 7210
I14-7746
LS-177674
Lumefantrine
Lumefantrine (INN)
Lumefantrine [INN:BAN]
MolPort-006-394-826
NCGC00167490-01
UNII-F38R0JR742
|
|
25 |
|
Antiprotozoal Agents |
|
Phase 1 |
|
|
|
26 |
|
Antimalarials |
|
Phase 1 |
|
|
|
27 |
|
Artemether, Lumefantrine Drug Combination |
|
Phase 1 |
|
|
|
28 |
|
Vaccines |
|
Phase 1 |
|
|
|
29 |
|
Artesunate |
Approved, Investigational |
|
|
88495-63-0 |
6917864 5464098 |
Synonyms:
(3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, hydrogen succinate
112346-66-4
182824-33-5
252637-87-9
4-Oxo-4-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate
4-oxo-4-{[(3r,5as,6r,8as,9r,10r,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid
83507-69-1
88495-63-0
91487-94-4
AC1L23PW
AC1L2XWW
AC1L4FU0
AC1Q5VRV
AKOS004119951
Ambap88495-63-0
Arinate
Arsumax
Arsumax (TN)
Artesunate
Artesunate (superseded RN)
Artesunate (USAN)
Artesunato
Artesunato [INN-Spanish]
Artesunatum
Artesunatum [INN-Latin]
Artesunic acid
Artsuna
AS
BB_NC-1045
Butanedioate, 1-[(3R,5as,6R,8as,9R,10S,12R,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-J]-1,2-benzodioxepin-10-yl] ester
Butanedioic acid, mono((3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester
Butanedioic acid, 1-[(3R,5as,6R,8as,9R,10S,12R,12ar)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-J]-1,2-benzodioxepin-10-yl] ester
Butanedioic acid, mono(decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester
C19H28O8
CHEMBL218601
CHEMBL258608
CID105031
CID11520210
CID11988384
CID156252
|
CID5464098
CID65664
CID6917864
CID9821433
CPD000466336
D02482
Dihydroartemisinine-12-alpha-succinate
Dihydroqinghaosusuccinate
dihydroqinghasu hemsuccinate
Dihydroqinghasu hemsuccinate
Dihydroqinghasu hemsuccinic acid
FT-0082543
HMS2051I14
HMS2090L16
HSDB 7458
I06-0204
LS-177760
LS-187735
Malacef
Malartin
MLS000759445
MLS001424053
MolPort-001-732-325
MolPort-006-392-384
NCI60_039350
NSC712571
Nuartez
Plasmotrim
Plasmotrin
Qinghaozhi
Quinghaosu reduced succinate ester
S2265_Selleck
SAM001246628
SM 804
SMR000466336
Sodium artesunate
STK801911
Succinyl dihydroartemisinin
UNII-60W3249T9M
WR 256283
WR-256283
|
|
30 |
|
Antiviral Agents |
|
|
|
|
|
Interventional clinical trials:
(show all 13)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
A Multi-centre, Open-label Randomised Trial to Assess the Efficacy, Safety and Tolerability of the Triple ACT Artemether-lumefantrine+Amodiaquine (AL+AQ) Compared to the ACT Artemether-lumefantrine (AL) in Uncomplicated Falciparum Malaria in Cambodia and Vietnam |
Unknown status |
NCT03355664 |
Phase 3 |
ACT;TACT |
2 |
A Double-Blind, Placebo-Controlled Trial of Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis |
Completed |
NCT00002191 |
Phase 3 |
Albendazole |
3 |
A Phase III, Randomised, Open Labelled, Active Controlled, Multi Centre, Superiority Trial of ArTiMistâ„¢ Versus Intravenous Quinine in Children With Severe or Complicated Falciparum Malaria, or Uncomplicated Falciparum Malaria With Gastrointestinal Complications. |
Completed |
NCT01258049 |
Phase 3 |
Artemether Sublingual Spray;Quinine |
4 |
An Open Label Randomised Comparative Trial to Establish the Efficacy of 3 mg/kg ArTiMistâ„¢ When Compared to Intravenous Quinine in Children With Severe or Complicated Falciparum Malaria, or Uncomplicated Falciparum Malaria With Gastrointestinal Complications |
Completed |
NCT01047436 |
Phase 2 |
Quinine;Artemether |
5 |
Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis |
Active, not recruiting |
NCT03441893 |
Phase 1, Phase 2 |
Nitazoxanide 500Mg Oral Tablet;Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet;Mesalazine 250Mg |
6 |
Randomized, Double-blind, Placebo-controlled Sequential Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SCYX-7158 After Single Oral Ascending Doses in Healthy Male Volunteers |
Completed |
NCT01533961 |
Phase 1 |
SCYX-7158;Placebo |
7 |
A Single Centre, Open Label, Pilot Phase Ib Study to Investigate Blood Stage Malaria Infection After Direct Venous Inoculation of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites (PfSPZ-DVI) in Malaria naïve Healthy Adult Volunteers |
Recruiting |
NCT04310085 |
Phase 1 |
Artemether-Lumefantrine 20 Mg-120 Mg Oral Tablet |
8 |
PCR in Blood Cultures of Individuals With Positive and Inconclusive Serology for Chagas' Disease |
Completed |
NCT00511589 |
|
|
9 |
Assessment of the Use of Fixed Doses of Artesunate Plus Amodiaquine Combination for the Home Management of Presumed Malaria in Malagasy Children |
Completed |
NCT00612547 |
|
Artesunate + Amodiaquine Fixed Dose Combination (CoArsucam) |
10 |
A Pilot Study to Optimise Controlled Human Malaria Infections Using Plasmodium Falciparum Sporozoites Administered by Needle and Syringe |
Completed |
NCT01465048 |
|
|
11 |
Survey of Intestinal Protozoal Infections and Sexual Transmitted Diseases Among Targeted Cohorts |
Completed |
NCT00630162 |
|
|
12 |
Relative Efficacy of Two Regimens of Ante-helminthic Treatment |
Completed |
NCT00367627 |
|
Albendazole |
13 |
Intestinal Helminths and Protozoan Infections in Patients With Colorectal Cancer: Prevalence and Possible Association With Cancer Pathogenesis |
Active, not recruiting |
NCT03173001 |
|
|
Inferred drug relations via
UMLS
71
/
NDF-RT
50
:
acetyl sulfisoxazole
Aminoglycoside Antimicrobial [EPC]
Antiprotozoal [EPC]
Ciprofloxacin
Dihydrofolate Reductase Inhibitor Antimicrobial [EPC]
Dihydrofolate Reductase Inhibitor Antiprotozoal [EPC]
Eflornithine
Eflornithine Hydrochloride
ERYTHROMYCIN PWDR
gemifloxacin mesylate
Macrolide Antimicrobial [EPC]
Metronidazole
|
Metronidazole Hydrochloride
METRONIDAZOLE PWDR
nitazoxanide
Nitroimidazole Antimicrobial [EPC]
Pentamidine
Pentamidine Isethionate
Polyene Antimicrobial [EPC]
Sulfisoxazole
Sulfisoxazole Diolamine
Sulfonamide Antimicrobial [EPC]
Tetracycline-class Antimicrobial [EPC]
Tinidazole
|
|